End-of-life care accounts for a good deal of total health care spending and Medicare obviously pays for a lot of that end-of-life care. A research letter in JAMA Internal Medicine analyzes whether the slowdown in Medicare fee-for-service spending is in part due to any reduction in the costs of end-of-life care. (JAMA Int. Med. Article) The authors used constant dollar spending data from 2004 to 2014 to evaluate the spending on people who died in the two years prior to death. Per beneficiary Medicare expenditures went from $9119 in 2004 to $10458 in 2009 to $9589 in 2014. Much of the recent decline is attributable to lower per capita spending on decedents and this decrease is driven by lower intensity of service. Inpatient, physician and home health service cost reductions were the major sources of lower spending, with inpatient making a particularly notable contribution, suggesting that more people are avoiding intensive hospital stays when enduring a critical illness near the end-of-life. Among all beneficiaries, per capita home health spending rose during the period, while it stayed relatively flat for decedents, indicating that this troublesome category was better managed for those near death. Hospital outpatient spending was also more restrained for decedents than for the total population. The study suggests that efforts to rein in use of expensive care in futile situations may be having an effect.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Best Buy is another large corporation trying to make a bet on health care, in this case largely by providing remote patient monitoring services. The company made yet another significant...
October 13, 2021
Just so men don’t feel left out, a company called Numan has raised $40 million for an app, yada, yada, yada, helping men with ED and other health issues. Also...
October 11, 2021
Money streams in to Flo, which sells an app for women to track menstrual cycles, etc. Investors hope they won’t be left up a creek. $100 million in financing that...
October 11, 2021
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace